Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS).
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15037702.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors investigated the relationship between statin use and the risk of stroke in the Heart and Estrogen-Progestin Replacement Study (HERS). Despite large reductions in relative risk point estimates, statin use was not associated with differences in the risks of all fatal stroke (relative hazard [RH] 0.52, 95% CI 0.23 to 1.18, p = 0.12), fatal ischemic stroke (RH 0.51, 95% CI 0.18 to 1.45, p = 0.21), fatal hemorrhagic stroke (RH 0.18, 95% CI 0.02 to 1.46, p = 0.11), or TIA (RH 1.32, 95% CI 0.84 to 2.09, p = 0.23).
Medical subject headings
- Estrogen Replacement Therapy
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Ischemic Attack, Transient
- Stroke